Curcumin prevents obesity, diabetes and fatty liver
By Jimmy Downs
Saturday April 27, 2013 (foodconsumer.org) -- curcumin an ingredient found in turmeric has been used to prevent many chronic diseases including obesity, type 2 diabetes and liver disease. Recent studies show that this dietary supplement possesses potent antioxidant, anticarcinogenic, antiinflammatory and hypoglycemic properties.
A new study in Journal of Physiology and Biochemistry has now found that curcumin supplementation reduces serum fetuin-A, which is involved in metabolic disorders such as visceral obesity, insulin resistance, diabetes and fatty liver, according to clinical studies.
For the study, Yildiz Öner-?yido?an and colleagues examined the effect of curcumin treatment on serum fetuin-A concentrations and hepatic lipids and antioxidant status in rats fed a high fat diet.
Rats fed 100 and 400 mg/kg body weight per day had reduced levels of liver triglycerides and serum fetuin A levels, the researchers found.
It is believed that 10 grams of curcumin per day is safe for humans to use. In a prior study, Indian researchers tested 6 grams of curcumin per day in people with pre-diabetes and found the dietary supplement very effective in preventing type 2 diabetes in the subjects.
- New Proof that This Common Medical Treatment is Unnecessary and Ineffective
- "Paleo" Diet Leads to Worsening Cholesterol
- Dietary supplements enlisted to fight obesity
- L-carnitine, coenzyme Q10 reduce toxicity of statins
- Addictive and Toxic: Found in Bread, Pasta Sauce and Salad Dressing